News | Embolic Protection Devices | August 03, 2018

Boston Scientific Closes Claret Medical Acquisition, Announces Positive Reimbursement Decision

CMS grants NTAP designation for the Sentinel Cerebral Protection System

Boston Scientific Closes Claret Medical Acquisition, Announces Positive Reimbursement Decision

August 3, 2018 — Boston Scientific Corp. announced it has recently closed its acquisition of Claret Medical Inc., a privately-held company that developed and commercialized the Sentinel Cerebral Embolic Protection System. The device is U.S. Food and Drug Administration (FDA)-cleared to protect patients against the risk of stroke in transcatheter aortic valve replacement (TAVR) procedures.

Boston Scientific also announced that the U.S. Centers for Medicare and Medicaid Services (CMS) granted a New Technology Add-on Payment (NTAP) designation for the Sentinel system.

The NTAP designation was granted as part of the federal fiscal year 2019 Inpatient Prospective Payment System (IPPS). The NTAP designation, awarded to new medical devices determined to substantially improve the diagnosis or treatment of Medicare beneficiaries, will be effective on Oct. 1, 2018.

The Sentinel System – which received CE Mark in 2014 and FDA clearance in 2017 – is the only device commercially available used to protect patients against the risk of stroke during TAVR, a minimally-invasive procedure to replace the aortic valve in patients with severe aortic stenosis. Embolic debris such as calcium or tissue can break loose during the procedure, travel through the bloodstream towards the brain and potentially cause neurological and neurocognitive damage. Recent studies have estimated approximately four percent of patients experience a clinically-apparent stroke within 30 days of a TAVR procedure.1,2,3,4,5,6 The landmark SENTINEL trial, which led to regulatory clearance, demonstrated that the Sentinel System reduced the incidence of strokes by 63 percent within the first 72 hours of the procedure.7  

Boston Scientific announced a definitive agreement to acquire Claret Medical on July 20, 2018 for $220 million in up-front cash with an additional $50 million payment for reaching a reimbursement-based milestone, which has been fulfilled with the recent NTAP designation.

For more information: www.bostonscientific.com

 

References

1. Leon, et al., N Engl J Med. 2010;363:1597-1607.

2. Webb, et al., J Am Coll Cardiol Intv. 2015;8:1797-1806.

3. Smith, et al., N Engl J Med. 2011;364:2187-98.

4. Leon, et al., N Engl J Med 2016;374:1609-20.

5. Popma, et al., J Am Coll Cardiol 2014;63:1972-81.

6. Adams, et al., N Engl J Med 2014;370:1790-98.

7. Kapadia S, et al. JACC. Jan 2017; 69(4): 367-377.

Related Content

News | Cardiovascular Business

June 28, 2022 — – Atlas Healthcare Partners – which specializes in developing and managing ambulatory surgery centers ...

Home June 28, 2022
Home
News | Cardiovascular Business

June 22, 2022 — Dr. Thomas Forbes, an interventional cardiologist, has joined Joe DiMaggio Children’s Hospital as its ...

Home June 22, 2022
Home
News | Cardiovascular Business

June 7, 2022 — Michael Bowdish, MD, MS, a national leader in cardiac surgery and among a handful of cardiac surgeons ...

Home June 07, 2022
Home
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of May ...

Home June 01, 2022
Home
News | Cardiovascular Business

May 25, 2022 — MedStar Heart & Vascular Institute announced that Thomas E. MacGillivray, MD, has been named physician ...

Home May 25, 2022
Home
News | Cardiovascular Business

May 16, 2022 — Boston Scientific announced that Peter M. “Pete” Nicholas, co-founder and former CEO of Boston Scientific ...

Home May 16, 2022
Home
News | Cardiovascular Business

May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more ...

Home May 12, 2022
Home
News | Cardiovascular Business

May 12, 2022 — NDA Partners General Manager, Eric Fish, announced today that Peter Mackrell, MD, a board certified ...

Home May 12, 2022
Home
News | Cardiovascular Business

May 11, 2022 — Vital Heart & Vein, a leading provider of cardiovascular and vein health, has named Gay Nord as its new ...

Home May 11, 2022
Home
Feature | Cardiovascular Business

Here are the top 10 performing videos on the Diagnostic and Interventional Cardiology (DAIC) website during the month of ...

Home May 09, 2022
Home
Subscribe Now